The fast-paced and tech-driven world has become a tougher proving grounds for the companies of today: corporate lifespans in the United States have shrunk to 30 years, and the 5-year mortality rate (before a company gets bought over or fails) has risen to a staggering 32 per cent.
Yet some firms hold out despite the volatile economy, and some even pivot to thrive in new circumstances. What are these companies doing that the traditionally-governed ones aren’t? Author and consultant of Boston Consulting Group, Martin Reeves, addresses this question with an digestible analogy: the immune system.
(RELATED: How Kodak fought its way out of bankruptcy.)